| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | TUT4 SETX AGO2 RBBP8 SMARCAD1 INO80 ERI2 GTDC1 DICER1 BPTF MLH3 POLR1B PRIMPOL | 1.05e-04 | 645 | 117 | 13 | GO:0140640 |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 1.57e-04 | 262 | 117 | 8 | GO:0140097 | |
| GeneOntologyCellularComponent | NLRP1 inflammasome complex | 3.38e-06 | 6 | 117 | 3 | GO:0072558 | |
| GeneOntologyCellularComponent | non-canonical inflammasome complex | 3.11e-05 | 2 | 117 | 2 | GO:0160074 | |
| GeneOntologyCellularComponent | canonical inflammasome complex | 1.31e-04 | 18 | 117 | 3 | GO:0061702 | |
| GeneOntologyCellularComponent | PR-DUB complex | 1.85e-04 | 4 | 117 | 2 | GO:0035517 | |
| GeneOntologyCellularComponent | postsynapse | AGO2 ATR VEZT MYO9A APBA2 LRRTM3 CBLB DICER1 ASAP1 NEDD4 AKAP9 GPR158 MTMR2 MACF1 AGAP2 | 5.59e-04 | 1018 | 117 | 15 | GO:0098794 |
| GeneOntologyCellularComponent | stereocilia coupling link | 8.51e-04 | 8 | 117 | 2 | GO:0002139 | |
| MousePheno | abnormal meiosis | 4.02e-06 | 241 | 92 | 10 | MP:0001930 | |
| MousePheno | abnormal cell cycle | SETX ATR RBBP8 DICER1 NEDD4 FANCC MLH3 AKAP9 CCNB3 NXF5 DIAPH3 PRIMPOL MYBL1 BRWD1 | 7.13e-06 | 520 | 92 | 14 | MP:0003077 |
| MousePheno | abnormal sex determination | SETX ZNF148 ATR ZFPM2 NEDD4 FANCC EBF2 NHSL1 FANCB SMYD4 LRGUK MLH3 AKAP9 WDR11 NXF5 TNFAIP3 GOLGA3 MYBL1 BRWD1 | 1.00e-05 | 945 | 92 | 19 | MP:0002210 |
| MousePheno | abnormal primary sex determination | SETX ZNF148 ATR ZFPM2 NEDD4 FANCC EBF2 NHSL1 FANCB SMYD4 LRGUK MLH3 AKAP9 WDR11 NXF5 GOLGA3 MYBL1 BRWD1 | 1.95e-05 | 901 | 92 | 18 | MP:0002211 |
| MousePheno | absent distal visceral endoderm | 4.28e-05 | 2 | 92 | 2 | MP:0012161 | |
| MousePheno | small gonad | SETX ZNF148 ATR NEDD4 FANCC EBF2 NHSL1 FANCB SMYD4 LRGUK MLH3 AKAP9 WDR11 NXF5 GOLGA3 MYBL1 BRWD1 | 5.65e-05 | 885 | 92 | 17 | MP:0001116 |
| MousePheno | small testis | SETX ZNF148 ATR FANCC EBF2 NHSL1 FANCB SMYD4 LRGUK MLH3 AKAP9 WDR11 NXF5 GOLGA3 MYBL1 BRWD1 | 8.38e-05 | 823 | 92 | 16 | MP:0001147 |
| MousePheno | abnormal gametogenesis | SETX ATR SMARCAD1 DZIP1 DICER1 NEDD4 FANCC FANCB LRGUK MLH3 AKAP9 WDR11 CCNB3 NXF5 MTMR2 GOLGA3 MYBL1 BRWD1 | 1.81e-04 | 1070 | 92 | 18 | MP:0001929 |
| MousePheno | abnormal circulating interleukin-18 level | 2.10e-04 | 18 | 92 | 3 | MP:0008634 | |
| MousePheno | abnormal oogenesis | 2.23e-04 | 186 | 92 | 7 | MP:0001931 | |
| MousePheno | abnormal female meiosis | 2.27e-04 | 84 | 92 | 5 | MP:0005168 | |
| MousePheno | abnormal distal visceral endoderm morphology | 2.55e-04 | 4 | 92 | 2 | MP:0010126 | |
| MousePheno | abnormal testis size | SETX ZNF148 ATR FANCC EBF2 NHSL1 FANCB SMYD4 LRGUK MLH3 AKAP9 WDR11 NXF5 GOLGA3 MYBL1 BRWD1 | 2.84e-04 | 915 | 92 | 16 | MP:0004849 |
| Domain | Pept_C14A_CASP1-typ | 8.66e-06 | 7 | 119 | 3 | IPR017350 | |
| Domain | Caspase_his_AS | 5.32e-05 | 12 | 119 | 3 | IPR016129 | |
| Domain | CASPASE_CYS | 5.32e-05 | 12 | 119 | 3 | PS01122 | |
| Domain | Pept_C14_p10 | 5.32e-05 | 12 | 119 | 3 | IPR002138 | |
| Domain | Caspase_cys_AS | 5.32e-05 | 12 | 119 | 3 | IPR033139 | |
| Domain | CASPASE_P10 | 5.32e-05 | 12 | 119 | 3 | PS50207 | |
| Domain | CASc | 6.88e-05 | 13 | 119 | 3 | SM00115 | |
| Domain | Pept_C14A | 6.88e-05 | 13 | 119 | 3 | IPR015917 | |
| Domain | - | 8.72e-05 | 14 | 119 | 3 | 3.40.50.1460 | |
| Domain | Pept_C14_p20 | 8.72e-05 | 14 | 119 | 3 | IPR001309 | |
| Domain | Caspase-like_dom | 8.72e-05 | 14 | 119 | 3 | IPR029030 | |
| Domain | CASPASE_P20 | 8.72e-05 | 14 | 119 | 3 | PS50208 | |
| Domain | Adaptor_Cbl_EF_hand-like | 1.20e-04 | 3 | 119 | 2 | IPR014741 | |
| Domain | HARE-HTH | 1.20e-04 | 3 | 119 | 2 | PF05066 | |
| Domain | Adaptor_Cbl_SH2-like | 1.20e-04 | 3 | 119 | 2 | IPR014742 | |
| Domain | ASXH | 1.20e-04 | 3 | 119 | 2 | PF13919 | |
| Domain | PHD_3 | 1.20e-04 | 3 | 119 | 2 | PF13922 | |
| Domain | ASX-like_PHD | 1.20e-04 | 3 | 119 | 2 | IPR026905 | |
| Domain | ASXH | 1.20e-04 | 3 | 119 | 2 | IPR028020 | |
| Domain | Adaptor_Cbl | 1.20e-04 | 3 | 119 | 2 | IPR024162 | |
| Domain | Cbl_PTB | 1.20e-04 | 3 | 119 | 2 | IPR024159 | |
| Domain | Cbl_N2 | 1.20e-04 | 3 | 119 | 2 | PF02761 | |
| Domain | Cbl_N3 | 1.20e-04 | 3 | 119 | 2 | PF02762 | |
| Domain | ASX/ASX-like | 1.20e-04 | 3 | 119 | 2 | IPR024811 | |
| Domain | Cbl_N | 1.20e-04 | 3 | 119 | 2 | PF02262 | |
| Domain | HB1/Asxl_HTH | 1.20e-04 | 3 | 119 | 2 | IPR007759 | |
| Domain | Adaptor_Cbl_N_hlx | 1.20e-04 | 3 | 119 | 2 | IPR003153 | |
| Domain | CBL_PTB | 1.20e-04 | 3 | 119 | 2 | PS51506 | |
| Domain | - | 1.20e-04 | 3 | 119 | 2 | 1.20.930.20 | |
| Domain | CARD | 7.35e-04 | 28 | 119 | 3 | PF00619 | |
| Domain | MACPF_2 | 8.28e-04 | 7 | 119 | 2 | PS51412 | |
| Domain | MACPF_1 | 8.28e-04 | 7 | 119 | 2 | PS00279 | |
| Domain | CARD | 9.95e-04 | 31 | 119 | 3 | IPR001315 | |
| Domain | CARD | 1.20e-03 | 33 | 119 | 3 | PS50209 | |
| Domain | PAZ | 1.41e-03 | 9 | 119 | 2 | PS50821 | |
| Domain | PAZ | 1.41e-03 | 9 | 119 | 2 | SM00949 | |
| Domain | PAZ | 1.41e-03 | 9 | 119 | 2 | PF02170 | |
| Domain | PAZ_dom | 1.41e-03 | 9 | 119 | 2 | IPR003100 | |
| Domain | CYCLIN | 1.81e-03 | 38 | 119 | 3 | SM00385 | |
| Domain | - | 2.10e-03 | 40 | 119 | 3 | 1.10.472.10 | |
| Domain | CASPASE_HIS | 2.13e-03 | 11 | 119 | 2 | PS01121 | |
| Domain | MACPF | 2.13e-03 | 11 | 119 | 2 | PF01823 | |
| Domain | MACPF | 2.55e-03 | 12 | 119 | 2 | IPR020864 | |
| Domain | MACPF | 2.55e-03 | 12 | 119 | 2 | SM00457 | |
| Domain | Ank_2 | 2.56e-03 | 215 | 119 | 6 | PF12796 | |
| Domain | Cyclin-like | 2.58e-03 | 43 | 119 | 3 | IPR013763 | |
| Domain | CARD | 4.56e-03 | 16 | 119 | 2 | SM00114 | |
| Domain | - | 5.14e-03 | 248 | 119 | 6 | 1.25.40.20 | |
| Domain | ANK | 5.45e-03 | 251 | 119 | 6 | SM00248 | |
| Domain | ANK_REPEAT | 5.66e-03 | 253 | 119 | 6 | PS50088 | |
| Domain | Ankyrin_rpt-contain_dom | 5.77e-03 | 254 | 119 | 6 | IPR020683 | |
| Domain | ANK_REP_REGION | 5.77e-03 | 254 | 119 | 6 | PS50297 | |
| Pubmed | PITPNM2 SETX AGO2 SANBR DZIP1 INO80 ERI2 FEM1C MELK PREPL DICER1 ANKRD27 STOX2 AKAP11 CEP126 | 5.46e-10 | 529 | 121 | 15 | 14621295 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | SETX MYO9A STXBP4 DZIP1 CBL TTK MELK ANKRD27 NEDD4 NHSL1 STOX2 OPTN AKAP9 CCDC138 MACF1 AKAP11 MPHOSPH9 TNFAIP3 | 1.20e-09 | 861 | 121 | 18 | 36931259 |
| Pubmed | Unpackaging the genetics of mammalian fertility: strategies to identify the "reproductive genome". | 1.99e-09 | 16 | 121 | 5 | 29878059 | |
| Pubmed | ZSWIM8 TUT4 AGO2 ZNF148 VEZT APBA2 SMARCAD1 INO80 DICER1 NSRP1 BPTF MLH3 RNH1 CCNB3 SMARCC1 MACF1 TAF2 BRWD1 | 6.43e-08 | 1116 | 121 | 18 | 31753913 | |
| Pubmed | Comparative study of apoptosis-related gene loci in human, mouse and rat genomes. | 1.64e-07 | 4 | 121 | 3 | 15880263 | |
| Pubmed | TBC1D15 ZNF148 VEZT DYNC2H1 STXBP4 SMARCAD1 DZIP1 TTK PREPL DICER1 NSRP1 AKAP9 WDR11 CCDC138 MACF1 AKAP11 WDR41 DIAPH3 GOLGA3 HERC5 | 2.10e-07 | 1487 | 121 | 20 | 33957083 | |
| Pubmed | Regulation of LFA-1-dependent inflammatory cell recruitment by Cbl-b and 14-3-3 proteins. | 4.09e-07 | 5 | 121 | 3 | 18239087 | |
| Pubmed | CIN85, a Cbl-interacting protein, is a component of AMAP1-mediated breast cancer invasion machinery. | 1.42e-06 | 7 | 121 | 3 | 17255943 | |
| Pubmed | 2.27e-06 | 8 | 121 | 3 | 9038361 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | DYNC2H1 APBA2 FEM1C MELK PREPL DICER1 LRR1 OPTN RNH1 POLR1B ZNF770 ASXL2 MPHOSPH9 TNFAIP3 DCAF4 | 2.30e-06 | 1005 | 121 | 15 | 19615732 |
| Pubmed | Prodomains--adaptors--oligomerization: the pursuit of caspase activation in apoptosis. | 3.40e-06 | 9 | 121 | 3 | 10087912 | |
| Pubmed | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | ZSWIM8 TUT4 MYO9A SANBR INO80 TTK NSRP1 NEDD4 TAX1BP1 ZNF506 POLR1B MPHOSPH9 TNFAIP3 BRWD1 | 4.37e-06 | 925 | 121 | 14 | 28986522 |
| Pubmed | 4.65e-06 | 32 | 121 | 4 | 19285159 | ||
| Pubmed | 4.84e-06 | 10 | 121 | 3 | 16503409 | ||
| Pubmed | Divinations and surprises: genetic analysis of caspase function in mice. | 4.84e-06 | 10 | 121 | 3 | 10739653 | |
| Pubmed | TUT4 RBL2 CASP5 ERI2 PKHD1L1 THAP2 CHIC2 MTMR2 CKAP2L TNFAIP3 CEP126 KDM6A | 5.21e-06 | 686 | 121 | 12 | 29987050 | |
| Pubmed | 6.64e-06 | 11 | 121 | 3 | 31999304 | ||
| Pubmed | CBLB ANKRD27 NEDD4 THAP2 OPTN TAX1BP1 MACF1 ASXL2 TNFAIP3 DIAPH3 KDM6A | 7.36e-06 | 591 | 121 | 11 | 15231748 | |
| Pubmed | 9.05e-06 | 209 | 121 | 7 | 36779422 | ||
| Pubmed | ZSWIM8 TRAF3IP1 RBL2 MCF2L2 APBA2 SMARCAD1 DZIP1 PREPL ZNF181 ZNF334 MTMR2 MACF1 KDM6A GOLGA3 AGAP2 BRWD1 | 1.03e-05 | 1285 | 121 | 16 | 35914814 | |
| Pubmed | 1.15e-05 | 13 | 121 | 3 | 12218189 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 23870309 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 17963913 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 11136825 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 18474237 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 21720866 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 15975932 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 27516385 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 25871390 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 39179968 | ||
| Pubmed | MicroRNA-Independent Modulation of DICER1 Expression by hAgo2. | 1.20e-05 | 2 | 121 | 2 | 32778571 | |
| Pubmed | Caspase-11-mediated tubular epithelial pyroptosis underlies contrast-induced acute kidney injury. | 1.20e-05 | 2 | 121 | 2 | 30250284 | |
| Pubmed | Caspase-11: the driving factor for noncanonical inflammasomes. | 1.20e-05 | 2 | 121 | 2 | 24037676 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 25712931 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 28850112 | ||
| Pubmed | Inflammatory caspases are innate immune receptors for intracellular LPS. | 1.20e-05 | 2 | 121 | 2 | 25119034 | |
| Pubmed | Cbl-b is a negative regulator of inflammatory cytokines produced by IgE-activated mast cells. | 1.20e-05 | 2 | 121 | 2 | 17056522 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 25943872 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 22763434 | ||
| Pubmed | Caspase-11 activation in response to bacterial secretion systems that access the host cytosol. | 1.20e-05 | 2 | 121 | 2 | 23762026 | |
| Pubmed | Association of a new c-Cbl related protein with the very first stages of apoptosis induction. | 1.20e-05 | 2 | 121 | 2 | 12102152 | |
| Pubmed | Cbl and Cbl-b control the germinal center reaction by facilitating naive B cell antigen processing. | 1.20e-05 | 2 | 121 | 2 | 32584413 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 8702803 | ||
| Pubmed | Mammalian caspases: structure, activation, substrates, and functions during apoptosis. | 1.20e-05 | 2 | 121 | 2 | 10872455 | |
| Pubmed | WW domain HECT E3s target Cbl RING finger E3s for proteasomal degradation. | 1.20e-05 | 2 | 121 | 2 | 12907674 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 20975942 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 10449734 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 25135428 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 21998596 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 23665906 | ||
| Pubmed | CASP4/caspase-11 promotes autophagosome formation in response to bacterial infection. | 1.20e-05 | 2 | 121 | 2 | 30165781 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 32103022 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 35862709 | ||
| Pubmed | c-Cbl and Cbl-b regulate T cell responsiveness by promoting ligand-induced TCR down-modulation. | 1.20e-05 | 2 | 121 | 2 | 12415267 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 34349759 | ||
| Pubmed | Inhibition of caspase-11 under inflammatory conditions suppresses chondrogenic differentiation. | 1.20e-05 | 2 | 121 | 2 | 38875922 | |
| Pubmed | Essential role of caspase-11 in activation-induced cell death of rat astrocytes. | 1.20e-05 | 2 | 121 | 2 | 11902113 | |
| Pubmed | Caspases determine the vulnerability of oligodendrocytes in the ischemic brain. | 1.20e-05 | 2 | 121 | 2 | 10974017 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 20353723 | ||
| Pubmed | Caspase-11-Mediated Cell Death Contributes to the Pathogenesis of Imiquimod-Induced Psoriasis. | 1.20e-05 | 2 | 121 | 2 | 31173764 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 14985426 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 29339744 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 10435631 | ||
| Pubmed | Caspase-11 Contributes to Oviduct Pathology during Genital Chlamydia Infection in Mice. | 1.20e-05 | 2 | 121 | 2 | 31160363 | |
| Pubmed | Caspase-11 attenuates gastrointestinal inflammation and experimental colitis pathogenesis. | 1.20e-05 | 2 | 121 | 2 | 25414099 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 19349980 | ||
| Pubmed | Caspase-11 Mediates Pyroptosis of Tubular Epithelial Cells and Septic Acute Kidney Injury. | 1.20e-05 | 2 | 121 | 2 | 31230050 | |
| Pubmed | The RNA-RNA base pairing potential of human Dicer and Ago2 proteins. | 1.20e-05 | 2 | 121 | 2 | 31655860 | |
| Pubmed | Caspase-11-mediated enteric neuronal pyroptosis underlies Western diet-induced colonic dysmotility. | 1.20e-05 | 2 | 121 | 2 | 32484462 | |
| Pubmed | Caspase-11 auto-proteolysis is crucial for noncanonical inflammasome activation. | 1.20e-05 | 2 | 121 | 2 | 30135078 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 34551309 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 38231198 | ||
| Pubmed | Shigella evades pyroptosis by arginine ADP-riboxanation of caspase-11. | 1.20e-05 | 2 | 121 | 2 | 34671164 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 26508369 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 7797592 | ||
| Pubmed | Stearoyl Lysophosphatidylcholine Inhibits Endotoxin-Induced Caspase-11 Activation. | 1.20e-05 | 2 | 121 | 2 | 28991049 | |
| Pubmed | Caspase-4 dimerisation and D289 auto-processing elicit an interleukin-1β-converting enzyme. | 1.20e-05 | 2 | 121 | 2 | 37558421 | |
| Pubmed | Casp11 Deficiency Alters Subgingival Microbiota and Attenuates Periodontitis. | 1.20e-05 | 2 | 121 | 2 | 38197150 | |
| Pubmed | Caspase-11 increases susceptibility to Salmonella infection in the absence of caspase-1. | 1.20e-05 | 2 | 121 | 2 | 22895188 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 27276677 | ||
| Pubmed | Novel c-CBL and CBL-b ubiquitin ligase mutations in human acute myeloid leukemia. | 1.20e-05 | 2 | 121 | 2 | 17475912 | |
| Pubmed | Protective role for caspase-11 during acute experimental murine colitis. | 1.20e-05 | 2 | 121 | 2 | 25548224 | |
| Pubmed | Essential Role for endogenous siRNAs during meiosis in mouse oocytes. | 1.20e-05 | 2 | 121 | 2 | 25695507 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 34916628 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 26177294 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 29061850 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 12843244 | ||
| Pubmed | Caspase-11 Plays a Protective Role in Pulmonary Acinetobacter baumannii Infection. | 1.20e-05 | 2 | 121 | 2 | 28760936 | |
| Pubmed | Loss of Cbl-PI3K interaction in mice prevents significant bone loss following ovariectomy. | 1.20e-05 | 2 | 121 | 2 | 24994594 | |
| Pubmed | Bacterial Outer Membrane Vesicles Mediate Cytosolic Localization of LPS and Caspase-11 Activation. | 1.20e-05 | 2 | 121 | 2 | 27156449 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 36776889 | ||
| Pubmed | Caspase-11-Mediated Hepatocytic Pyroptosis Promotes the Progression of Nonalcoholic Steatohepatitis. | 1.20e-05 | 2 | 121 | 2 | 33894425 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 25347553 | ||
| Pubmed | Activation of DSB processing requires phosphorylation of CtIP by ATR. | 1.20e-05 | 2 | 121 | 2 | 23273981 | |
| Pubmed | Role of caspase-11 non-canonical inflammasomes in retinal ischemia/reperfusion injury. | 1.20e-05 | 2 | 121 | 2 | 39333859 | |
| Pubmed | cAMP metabolism controls caspase-11 inflammasome activation and pyroptosis in sepsis. | 1.20e-05 | 2 | 121 | 2 | 31131320 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 25980012 | ||
| Pubmed | 1.81e-05 | 15 | 121 | 3 | 19536649 | ||
| Pubmed | 1.81e-05 | 15 | 121 | 3 | 19801895 | ||
| Pubmed | Expression of caspase and BCL-2 apoptotic family members in mouse preimplantation embryos. | 1.81e-05 | 15 | 121 | 3 | 10377054 | |
| Interaction | ELF4 interactions | 6.05e-06 | 115 | 121 | 7 | int:ELF4 | |
| Interaction | PTK2B interactions | 7.59e-06 | 119 | 121 | 7 | int:PTK2B | |
| Interaction | YWHAZ interactions | AGO2 COL6A6 MYO9A DZIP1 CBL MELK ITGB2 ANKRD27 NEDD4 NHSL1 STOX2 OPTN AKAP9 ASXL3 TAX1BP1 MACF1 AKAP11 ASXL2 MPHOSPH9 TNFAIP3 CEP126 GOLGA3 | 1.11e-05 | 1319 | 121 | 22 | int:YWHAZ |
| Interaction | GOLGA1 interactions | 1.49e-05 | 183 | 121 | 8 | int:GOLGA1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q22 | 1.00e-05 | 107 | 121 | 5 | chr11q22 | |
| Cytoband | 11q22.2-q22.3 | 2.06e-05 | 3 | 121 | 2 | 11q22.2-q22.3 | |
| Cytoband | 2q13 | 7.90e-04 | 68 | 121 | 3 | 2q13 | |
| Cytoband | 12q21.1 | 8.07e-04 | 16 | 121 | 2 | 12q21.1 | |
| Cytoband | 8q23 | 1.03e-03 | 18 | 121 | 2 | 8q23 | |
| GeneFamily | Caspases|Caspase recruitment domain containing | 1.90e-05 | 13 | 75 | 3 | 468 | |
| GeneFamily | WD repeat domain containing|Caspase recruitment domain containing|Apoptosome | 2.57e-04 | 30 | 75 | 3 | 959 | |
| GeneFamily | Ankyrin repeat domain containing | 5.03e-04 | 242 | 75 | 6 | 403 | |
| GeneFamily | X-linked mental retardation|Rho GTPase activating proteins|BAR-PH domain containing | 2.22e-03 | 17 | 75 | 2 | 1291 | |
| GeneFamily | WD repeat domain containing|DDB1 and CUL4 associated factors | 2.49e-03 | 18 | 75 | 2 | 498 | |
| GeneFamily | Ring finger proteins|Fanconi anemia complementation groups|Protein phosphatase 1 regulatory subunits|BRCA1 A complex|BRCA1 B complex|BRCA1 C complex | 3.07e-03 | 20 | 75 | 2 | 548 | |
| GeneFamily | Neuroblastoma breakpoint family | 4.06e-03 | 23 | 75 | 2 | 662 | |
| GeneFamily | Cyclins | 5.99e-03 | 28 | 75 | 2 | 473 | |
| GeneFamily | Zinc fingers MYND-type|A-kinase anchoring proteins | 6.41e-03 | 29 | 75 | 2 | 396 | |
| GeneFamily | ArfGAPs | 8.25e-03 | 33 | 75 | 2 | 395 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 9.64e-03 | 718 | 75 | 8 | 28 | |
| GeneFamily | Complement system|Sushi domain containing | 9.76e-03 | 36 | 75 | 2 | 492 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | TCEA1 TUT4 SETX ZNF148 ATR MYO9A RBBP8 SMARCAD1 DZIP1 TTK NSRP1 BPTF STOX2 OPTN WDR11 TAX1BP1 AKAP11 DIAPH3 MYBL1 | 1.84e-10 | 656 | 121 | 19 | M18979 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | TUT4 SETX AGO2 ZNF148 ATR CBLB TTK MELK DICER1 NEDD4 BPTF AKAP9 MACF1 AKAP11 MPHOSPH9 CXCL12 MYBL1 | 4.29e-07 | 856 | 121 | 17 | M4500 |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_UP | TCEA1 SETX ZNF148 ATR RBBP8 ERI2 MELK AKAP9 WDR11 TAX1BP1 ZNF770 TAF2 | 8.40e-07 | 434 | 121 | 12 | M15150 |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_UP | TCEA1 SETX ZNF148 ATR RBBP8 ERI2 MELK AKAP9 WDR11 TAX1BP1 ZNF770 TAF2 | 1.17e-06 | 448 | 121 | 12 | MM1044 |
| Coexpression | DE_YY1_TARGETS_DN | 4.69e-06 | 93 | 121 | 6 | M3278 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | TUT4 COL6A6 APBA2 PREPL DICER1 ZFPM2 EBF2 STOX2 OPTN AKAP9 GPR158 ASXL3 ANKAR CEP126 GOLGA3 CCDC144A BRWD1 | 1.33e-05 | 1106 | 121 | 17 | M39071 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | TUT4 SETX ZNF148 ATR RBL2 APBA2 CGGBP1 CBL CBLB ITGB2 DICER1 ASAP1 BPTF AKAP9 MACF1 AKAP11 ASXL2 TNFAIP3 MYBL1 BRWD1 | 1.59e-05 | 1492 | 121 | 20 | M40023 |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | FUT10 AGO2 ATR VEZT RBBP8 SMARCAD1 TTK MELK ASAP1 NEDD4 CCNG1 THAP2 LRR1 POLR1B MPHOSPH9 DIAPH3 ZNF614 PRIMPOL L3MBTL4 | 2.41e-05 | 1407 | 121 | 19 | M14427 |
| Coexpression | GSE27241_CTRL_VS_DIGOXIN_TREATED_RORGT_KO_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_UP | 3.73e-05 | 197 | 121 | 7 | M8226 | |
| Coexpression | GSE1460_CORD_VS_ADULT_BLOOD_NAIVE_CD4_TCELL_UP | 3.73e-05 | 197 | 121 | 7 | M3480 | |
| Coexpression | ERBB2_UP.V1_DN | 3.73e-05 | 197 | 121 | 7 | M2635 | |
| Coexpression | GSE37532_WT_VS_PPARG_KO_VISCERAL_ADIPOSE_TISSUE_TREG_UP | 3.98e-05 | 199 | 121 | 7 | M8961 | |
| Coexpression | GSE21927_C26GM_VS_4T1_TUMOR_MONOCYTE_BALBC_DN | 3.98e-05 | 199 | 121 | 7 | M7607 | |
| Coexpression | GSE23321_CD8_STEM_CELL_MEMORY_VS_EFFECTOR_MEMORY_CD8_TCELL_DN | 3.98e-05 | 199 | 121 | 7 | M8430 | |
| Coexpression | GSE15750_DAY6_VS_DAY10_EFF_CD8_TCELL_UP | 4.11e-05 | 200 | 121 | 7 | M3577 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 6.25e-05 | 466 | 121 | 10 | M13522 | |
| Coexpression | KIM_MYCN_AMPLIFICATION_TARGETS_UP | 7.25e-05 | 93 | 121 | 5 | M18532 | |
| Coexpression | GSE12507_PDC_CELL_LINE_VS_IMMATUE_T_CELL_LINE_UP | 7.93e-05 | 153 | 121 | 6 | M438 | |
| Coexpression | VANTVEER_BREAST_CANCER_ESR1_DN | 8.39e-05 | 224 | 121 | 7 | M15425 | |
| Coexpression | SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP | 8.85e-05 | 305 | 121 | 8 | M19875 | |
| Coexpression | KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP | TCEA1 AGO2 ATR TTK MELK DICER1 ASAP1 NEDD4 SMYD4 LRR1 CCDC138 CKAP2L SMARCC1 MPHOSPH9 TAF2 PRIMPOL MYBL1 | 9.12e-05 | 1290 | 121 | 17 | M80 |
| Coexpression | DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP | 1.31e-04 | 323 | 121 | 8 | M2156 | |
| Coexpression | FARMER_BREAST_CANCER_APOCRINE_VS_BASAL | 1.49e-04 | 329 | 121 | 8 | M2631 | |
| Coexpression | GSE9601_UNTREATED_VS_NFKB_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_DN | 1.61e-04 | 174 | 121 | 6 | M6881 | |
| Coexpression | GSE13547_2H_VS_12_H_ANTI_IGM_STIM_BCELL_UP | 1.71e-04 | 176 | 121 | 6 | M2981 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP | ATR DYNC2H1 RBBP8 TTK NEDD4 LRR1 ASXL2 WDR41 DIAPH3 MYBL1 BRWD1 | 2.01e-04 | 644 | 121 | 11 | M10501 |
| Coexpression | ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_DN | FUT10 TUT4 RBL2 APBA2 CBLB PREPL ZNF181 CCNG1 BPTF ZNF506 MACF1 MPHOSPH9 MYBL1 BRWD1 | 2.44e-04 | 1012 | 121 | 14 | M40864 |
| Coexpression | GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_CD4_TCELL_UP | 2.89e-04 | 194 | 121 | 6 | M7467 | |
| Coexpression | GSE22886_NAIVE_VS_MEMORY_TCELL_UP | 2.89e-04 | 194 | 121 | 6 | M4416 | |
| Coexpression | GSE22886_NAIVE_CD8_TCELL_VS_MEMORY_TCELL_UP | 2.97e-04 | 195 | 121 | 6 | M4405 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_EARLY_STALK_CELL | SANBR APBA2 TTK MELK FANCB LRR1 CKAP2L TNFAIP3 DIAPH3 PHYHIPL | 3.06e-04 | 567 | 121 | 10 | M45692 |
| Coexpression | GSE13411_IGM_VS_SWITCHED_MEMORY_BCELL_DN | 3.22e-04 | 198 | 121 | 6 | M3248 | |
| Coexpression | GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH2_UP | 3.22e-04 | 198 | 121 | 6 | M5591 | |
| Coexpression | GSE3039_ALPHABETA_CD8_TCELL_VS_B2_BCELL_UP | 3.31e-04 | 199 | 121 | 6 | M6443 | |
| Coexpression | GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY5_DN | 3.31e-04 | 199 | 121 | 6 | M4635 | |
| Coexpression | GSE26727_WT_VS_KLF2_KO_LPS_STIM_MACROPHAGE_UP | 3.31e-04 | 199 | 121 | 6 | M8301 | |
| Coexpression | GSE21063_WT_VS_NFATC1_KO_8H_ANTI_IGM_STIM_BCELL_UP | 3.31e-04 | 199 | 121 | 6 | M8277 | |
| Coexpression | GSE32986_GMCSF_AND_CURDLAN_LOWDOSE_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_UP | 3.31e-04 | 199 | 121 | 6 | M8639 | |
| Coexpression | ZHENG_FOXP3_TARGETS_IN_THYMUS_UP | 3.31e-04 | 199 | 121 | 6 | M1746 | |
| Coexpression | GSE28737_WT_VS_BCL6_HET_MARGINAL_ZONE_BCELL_DN | 3.40e-04 | 200 | 121 | 6 | M9344 | |
| Coexpression | GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_IL4_TREATED_MACROPHAGE_DN | 3.40e-04 | 200 | 121 | 6 | M7913 | |
| Coexpression | GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_OLD_DN | 3.40e-04 | 200 | 121 | 6 | M5303 | |
| Coexpression | HALLMARK_COMPLEMENT | 3.40e-04 | 200 | 121 | 6 | M5921 | |
| Coexpression | GSE23505_IL6_IL1_VS_IL6_IL1_IL23_TREATED_CD4_TCELL_UP | 3.40e-04 | 200 | 121 | 6 | M7869 | |
| Coexpression | GSE360_L_DONOVANI_VS_L_MAJOR_MAC_DN | 3.40e-04 | 200 | 121 | 6 | M5232 | |
| Coexpression | GSE42724_NAIVE_VS_MEMORY_BCELL_DN | 3.40e-04 | 200 | 121 | 6 | M9793 | |
| Coexpression | GSE22886_IGA_VS_IGM_MEMORY_BCELL_DN | 3.40e-04 | 200 | 121 | 6 | M4439 | |
| Coexpression | ZHENG_FOXP3_TARGETS_IN_THYMUS_UP | 3.40e-04 | 200 | 121 | 6 | MM1033 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_PROLIFERATING_SCHWANN_CELL | FUT10 RBBP8 CASP4 ERI2 HAUS2 TTK MELK FANCB SMYD4 LRR1 CKAP2L AKAP11 ASXL2 DIAPH3 | 3.67e-04 | 1054 | 121 | 14 | M45798 |
| Coexpression | FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_UP | TCEA1 NBPF11 CGGBP1 GTDC1 PKHD1L1 CCNG1 FANCB MTMR2 KDM6A ZNF614 | 4.02e-04 | 587 | 121 | 10 | M40869 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | TUT4 SETX ATR TRAF3IP1 RBBP8 STXBP4 SANBR SMARCAD1 CEP76 ERI2 TTK DICER1 NSRP1 THAP2 BPTF AKAP9 ZNF334 TAX1BP1 CCDC138 ZNF506 CKAP2L SMARCC1 MACF1 ZNF770 CEP126 PHYHIPL MYBL1 BRWD1 | 2.29e-10 | 1257 | 119 | 28 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | TUT4 SETX ATR TRAF3IP1 RBBP8 STXBP4 SANBR SMARCAD1 CEP76 ERI2 TTK DICER1 NSRP1 THAP2 BPTF AKAP9 ZNF334 TAX1BP1 CCDC138 ZNF506 CKAP2L SMARCC1 MACF1 ZNF770 CEP126 PHYHIPL MYBL1 BRWD1 | 6.40e-09 | 1459 | 119 | 28 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | TUT4 SETX ATR COL6A6 RBBP8 STXBP4 SANBR SMARCAD1 CEP76 DZIP1 ERI2 TTK THAP2 OPTN AKAP9 ZNF334 TAX1BP1 ZNF506 CKAP2L SMARCC1 ZNF770 ASXL2 CEP126 KDM6A MYBL1 | 2.26e-08 | 1252 | 119 | 25 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | TUT4 SETX STXBP4 SANBR MPEG1 SMARCAD1 CEP76 LRRTM3 ERI2 STOX2 AKAP9 ZNF334 CCDC138 TIGD3 ZNF506 CKAP2L SMARCC1 MACF1 CEP126 PHYHIPL MYBL1 BRWD1 | 9.34e-08 | 1060 | 119 | 22 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | TCEA1 TRAF3IP1 INO80 FEM1C DICER1 NSRP1 NEDD4 BPTF ZNF334 TAX1BP1 MACF1 ZNF770 ASXL2 PRIMPOL BRWD1 | 6.25e-07 | 564 | 119 | 15 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | TUT4 SETX TRAF3IP1 STXBP4 TTK ASXL3 ZNF506 CKAP2L MACF1 MPHOSPH9 CEP126 | 9.52e-07 | 298 | 119 | 11 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K4 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | TUT4 SETX ATR RBBP8 STXBP4 SMARCAD1 DZIP1 TTK NSRP1 CHIC2 OPTN AKAP9 ZNF334 ASXL3 ZNF506 CKAP2L SMARCC1 MACF1 ZNF770 CEP126 KDM6A BRWD1 | 1.36e-06 | 1241 | 119 | 22 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | TUT4 TRAF3IP1 STXBP4 TTK PREPL NSRP1 AKAP9 CKAP2L MACF1 MPHOSPH9 | 5.72e-06 | 291 | 119 | 10 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | TCEA1 TRAF3IP1 DYNC2H1 SANBR CEP76 FEM1C NSRP1 THAP2 BPTF TAX1BP1 TIGD3 MACF1 ASXL2 PHYHIPL | 6.26e-06 | 595 | 119 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_1000 | TUT4 VEZT INO80 CBLB HAUS2 ASAP1 BPTF CHIC2 AKAP9 ASXL2 BRWD1 | 9.55e-06 | 379 | 119 | 11 | gudmap_developingKidney_e15.5_1000_k3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | TUT4 TRAF3IP1 STXBP4 DICER1 NSRP1 AKAP9 CKAP2L MPHOSPH9 KDM6A MYBL1 | 1.02e-05 | 311 | 119 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | TUT4 SETX STXBP4 SANBR MPEG1 SMARCAD1 CEP76 LRRTM3 ERI2 STOX2 AKAP9 ZNF334 CCDC138 TIGD3 ZNF506 CKAP2L SMARCC1 MACF1 CEP126 PHYHIPL MYBL1 BRWD1 | 1.11e-05 | 1414 | 119 | 22 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | TRAF3IP1 MYO9A DYNC2H1 STXBP4 SANBR CEP76 GTDC1 PREPL NSRP1 CCNG1 AKAP9 MPHOSPH9 PHYHIPL KDM6A GOLGA3 MYBL1 | 1.63e-05 | 831 | 119 | 16 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500 | TUT4 SETX ATR RBBP8 STXBP4 SMARCAD1 DZIP1 TTK NSRP1 CHIC2 OPTN AKAP9 ZNF334 ASXL3 ZNF506 CKAP2L SMARCC1 MACF1 ZNF770 CEP126 KDM6A BRWD1 | 1.98e-05 | 1468 | 119 | 22 | facebase_RNAseq_e10.5_MandArch_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | TUT4 TRAF3IP1 MYO9A STXBP4 GTDC1 TTK PREPL NSRP1 CCNG1 AKAP9 CKAP2L MACF1 MPHOSPH9 KDM6A GOLGA3 | 3.11e-05 | 780 | 119 | 15 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | TCEA1 TUT4 TRAF3IP1 STXBP4 NSRP1 TAX1BP1 CKAP2L MACF1 ASXL2 PRIMPOL BRWD1 | 3.20e-05 | 432 | 119 | 11 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#1_top-relative-expression-ranked_1000 | 3.21e-05 | 159 | 119 | 7 | gudmap_developingGonad_e11.5_ovary + mesonephros_k1_1000 | |
| CoexpressionAtlas | DevelopingKidney_e11.5_metaneph mesench_emap-3843_k-means-cluster#4_top-relative-expression-ranked_1000 | 3.48e-05 | 161 | 119 | 7 | gudmap_developingKidney_e11.5_metaneph mesench_1000_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000 | TUT4 AGO2 TRAF3IP1 STXBP4 GTDC1 TTK PREPL NSRP1 NHSL1 AKAP9 RNH1 ASXL3 CKAP2L MACF1 AKAP11 MPHOSPH9 CXCL12 | 3.50e-05 | 985 | 119 | 17 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | TUT4 TRAF3IP1 DYNC2H1 STXBP4 SANBR CEP76 DICER1 NSRP1 EBF2 STOX2 AKAP9 CKAP2L MPHOSPH9 PHYHIPL KDM6A MYBL1 BRWD1 | 3.69e-05 | 989 | 119 | 17 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | TCEA1 TRAF3IP1 DYNC2H1 STXBP4 SANBR NSRP1 NEDD4 BPTF AKAP9 TAX1BP1 MACF1 ASXL2 PRIMPOL | 5.26e-05 | 629 | 119 | 13 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | 6.29e-05 | 385 | 119 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | SETX TRAF3IP1 RBBP8 STXBP4 TTK NSRP1 SMYD4 AKAP9 SMARCC1 MPHOSPH9 CEP126 | 6.71e-05 | 469 | 119 | 11 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | alpha beta T cells, NKT.44-NK1.1-.Th, aGC CD1d tet CD3e, Thymus, avg-2 | PITPNM2 CEP76 DZIP1 ERI2 TTK MELK CCNG1 CKAP2L SMARCC1 DIAPH3 | 8.29e-05 | 398 | 119 | 10 | GSM538338_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 8.67e-05 | 186 | 119 | 7 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500 | TUT4 AGO2 TRAF3IP1 RBBP8 NSRP1 EBF2 AKAP9 ASXL3 CKAP2L MACF1 MPHOSPH9 | 1.03e-04 | 492 | 119 | 11 | Facebase_RNAseq_e10.5_Mandibular Arch_500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_top-relative-expression-ranked_1000 | FBLN7 FUT10 TUT4 SETX ZNF148 DYNC2H1 STXBP4 DZIP1 INO80 LRR1 POLR1B ASXL2 MPHOSPH9 TAF2 | 1.19e-04 | 779 | 119 | 14 | gudmap_developingKidney_e15.5_Cap mesenchyme_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.01e-04 | 361 | 119 | 9 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k2_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | SETX ATR MYO9A RBBP8 TTK MELK FANCB LRR1 CCDC138 AKAP11 DIAPH3 PHYHIPL MYBL1 BRWD1 | 2.03e-04 | 820 | 119 | 14 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | TUT4 DYNC2H1 STXBP4 SANBR SMARCAD1 CEP76 ERI2 MELK BPTF STOX2 AKAP9 CCDC138 CKAP2L TAF2 CEP126 PHYHIPL KDM6A MYBL1 BRWD1 | 2.16e-04 | 1370 | 119 | 19 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.37e-04 | 369 | 119 | 9 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 3.14e-04 | 105 | 119 | 5 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_500_K4 | |
| CoexpressionAtlas | DevelopingKidney_e11.5_metaneph mesench_emap-3843_k-means-cluster#3_top-relative-expression-ranked_500 | 3.28e-04 | 106 | 119 | 5 | gudmap_developingKidney_e11.5_metaneph mesench_500_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#1_top-relative-expression-ranked_500 | 3.29e-04 | 231 | 119 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_500_k1 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#4_top-relative-expression-ranked_1000 | 4.07e-04 | 62 | 119 | 4 | gudmap_developingGonad_e11.5_testes_k4_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | TCEA1 TUT4 TRAF3IP1 STXBP4 SANBR LRRTM3 NSRP1 EBF2 AKAP9 TAX1BP1 CKAP2L MACF1 ASXL2 PRIMPOL BRWD1 | 4.23e-04 | 989 | 119 | 15 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | B cells, preB.FrC.BM, CD19+ IgM- CD45R+ CD43+ HSA+, Bone marrow, avg-3 | 5.01e-04 | 409 | 119 | 9 | GSM399452_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000_k-means-cluster#1 | 6.50e-04 | 259 | 119 | 7 | Facebase_RNAseq_e8.5_Floor Plate_1000_K1 | |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_k-means-cluster#4_top-relative-expression-ranked_1000 | 7.19e-04 | 72 | 119 | 4 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_k4_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 7.53e-04 | 192 | 119 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 7.53e-04 | 192 | 119 | 6 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | SETX RBBP8 SANBR SMARCAD1 CEP76 TTK SMARCC1 MPHOSPH9 CEP126 PHYHIPL | 8.31e-04 | 532 | 119 | 10 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | DevelopingKidney_e11.5_metaneph mesench_emap-3843_top-relative-expression-ranked_1000 | VEZT DYNC2H1 CBLB DICER1 EBF2 ZNF334 ASXL3 GPX6 MPHOSPH9 TNFAIP3 CXCL12 MYBL1 BRWD1 | 9.66e-04 | 850 | 119 | 13 | gudmap_developingKidney_e11.5_metaneph mesench_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | TUT4 SETX ZNF148 TRAF3IP1 STXBP4 DZIP1 TTK ASXL3 ZNF506 CKAP2L MACF1 MPHOSPH9 | 9.68e-04 | 744 | 119 | 12 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K4 |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 5.90e-08 | 193 | 121 | 8 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.40e-07 | 176 | 121 | 7 | 45c6983ab671b0f306e7390320bd84f848e474cc | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.61e-07 | 177 | 121 | 7 | 8a0f0fbb06cdacb99a3fdba0da3e0494b891db4f | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.61e-07 | 177 | 121 | 7 | 4197cf2b1e743230c821f422836fa5991b155a52 | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.61e-07 | 177 | 121 | 7 | e9d7682517fb30fd2ad535d59779d718a7024c13 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.05e-07 | 179 | 121 | 7 | 88d44b04eb5c079531db663ed98ddb20b60feb9a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.28e-07 | 180 | 121 | 7 | 401df9cddcbca1eb8f0d2687bcacd98e95dc1493 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.11e-07 | 187 | 121 | 7 | 9351fa87b69a951af85b10bf91fe9b1cce8c0517 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.40e-07 | 188 | 121 | 7 | af740fa78542438fdff627ea1f74f4eee43316be | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.00e-06 | 193 | 121 | 7 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.15e-06 | 197 | 121 | 7 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | 18-Airway-Mesenchymal-Mesenchyme_RSPO2+|Airway / Age, Tissue, Lineage and Cell class | 1.23e-06 | 199 | 121 | 7 | 7ac35e8f45dcdc702422dabd8f3e4d03e2bf61af | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Proliferating-Cycling_Progenitors|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.23e-06 | 199 | 121 | 7 | a99516a5760f49a69b0fe45a9b2316e393252966 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.23e-06 | 199 | 121 | 7 | 1d5a3366474c17e3df0ba5cf11b586655529e9bd | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.27e-06 | 200 | 121 | 7 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Stem_cells|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 1.27e-06 | 200 | 121 | 7 | 31dd81df9aa754a1e69b905bf9b8ce73ff8175aa | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Stem_cells-Neuroepithelial_cell|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 1.27e-06 | 200 | 121 | 7 | 54174a485a82480726fa06efa6e050ddea77cb3c | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Proliferating-cycling_ventral_progenitors|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 1.27e-06 | 200 | 121 | 7 | 9359faa749f41aaef70b4874f20b4eed2dc12cc2 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.27e-06 | 200 | 121 | 7 | af3dc76b4507bf4edd265169f5dfbbb8a19eb394 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.62e-06 | 163 | 121 | 6 | 5285318c52aa31c9b22dc2ffff078e32e408604d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.62e-06 | 163 | 121 | 6 | 3f434015c0cbefb31eeda133c34f75384c5f7e22 | |
| ToppCell | Dividing_Macrophages-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 6.91e-06 | 169 | 121 | 6 | eb0c993ef2eea73bc4881182520922ce9ae9368f | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.91e-06 | 169 | 121 | 6 | e0607af8ae8609d43e26ff2a2cab92650bfcd5b7 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.91e-06 | 169 | 121 | 6 | 121768fc51fc3441ec725346a1bbe29e21d05971 | |
| ToppCell | facs-Marrow-T-cells-3m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.15e-06 | 170 | 121 | 6 | d70aaa0f4e5034bb9f61b832b5f9123870936d3c | |
| ToppCell | Entopeduncular-Macroglia-POLYDENDROCYTE-P1|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 7.20e-06 | 98 | 121 | 5 | fca0baf13520c53edb6da2fe3eb152fbd44df5ed | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 7.39e-06 | 171 | 121 | 6 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.43e-06 | 175 | 121 | 6 | 876cea684faf42ff3eb4623ad6d7a1fb1276ee02 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 9.00e-06 | 177 | 121 | 6 | 26c25d10aa511b64cc7db43a8deea7b5d31bca96 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.29e-06 | 178 | 121 | 6 | ad3de3e03a401dac64431a541899445262246347 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.90e-06 | 180 | 121 | 6 | 334e2b1f6eb7d4ece20b1c7b02107863f913237f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-05 | 181 | 121 | 6 | 6956ecd6264f7469a25e555673bce4eb97d28f7a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-05 | 182 | 121 | 6 | 336cd05e46a741185ce3c59ee67a4b07fa6a5101 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-05 | 184 | 121 | 6 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.12e-05 | 184 | 121 | 6 | d1e0e3b0eed2db8a5b7e3d6f81294667e4ba64e5 | |
| ToppCell | Control-T_cells-Cycling_NK/T_cells|Control / group, cell type (main and fine annotations) | 1.16e-05 | 185 | 121 | 6 | 9766216b41ee62bbac4caa25cb98ec5627a24075 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-05 | 185 | 121 | 6 | 30e041d6f6e310d64809e9d6d93cd30052972f3b | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_Erythro-Mega-Mega-Mast|bone_marrow / Manually curated celltypes from each tissue | 1.16e-05 | 185 | 121 | 6 | a62ebaff92f2ed27b27b32c27c89cfbe2cb35116 | |
| ToppCell | Dividing_Macrophages-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.19e-05 | 186 | 121 | 6 | 0067eb78d4c7e32b9563550d9fcaf13445ee6a48 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-05 | 186 | 121 | 6 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.19e-05 | 186 | 121 | 6 | 20340a5b5cc7f07386498a4ef937d6fbc9e347c4 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-05 | 187 | 121 | 6 | c31130fc2f9f882944b2ba366a034a03f051c4b9 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.31e-05 | 189 | 121 | 6 | fd8834d1feb7f63911c5fa51efb1f679a8baddeb | |
| ToppCell | ILEUM-non-inflamed-(1)_T_cell-(1)_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.31e-05 | 189 | 121 | 6 | 2c8a2fb76ea002bac554bc1c761ce960b5e116e1 | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.35e-05 | 190 | 121 | 6 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | 3'_v3-GI_small-bowel-Myeloid_Mac-Cycling_Myeloid-Mac|GI_small-bowel / Manually curated celltypes from each tissue | 1.39e-05 | 191 | 121 | 6 | c3944332c5226b0113f8aa9ac07837b755606c6c | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.39e-05 | 191 | 121 | 6 | 50854384fdaa0efa2e3227659d544ed09ac102f2 | |
| ToppCell | (3)_Macrophage_Dividing|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.39e-05 | 191 | 121 | 6 | b42f0b89bb94fd43786ff50f1caeb3ebfbbb43fd | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.51e-05 | 194 | 121 | 6 | f9070035553bc68106a9e0bdf4b507715a138aba | |
| ToppCell | IPF-Endothelial-Lymphatic|Endothelial / Disease state, Lineage and Cell class | 1.56e-05 | 195 | 121 | 6 | de88e9d22044b4b3e29676ad02b3e9299cc920ad | |
| ToppCell | tumor_Lung-B_lymphocytes-GC_B_cells_in_the_DZ|B_lymphocytes / Location, Cell class and cell subclass | 1.56e-05 | 195 | 121 | 6 | 339e81a3a5b1f71c0d15ef1ef0f6999378704923 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Proliferating-Cycling_Progenitors|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.61e-05 | 196 | 121 | 6 | 5905f0e3061a6b98b7a33d64c782c3dda2cd51ef | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.61e-05 | 196 | 121 | 6 | 0f3c7fd450aaa1f866b8558692534c0ea2a34e75 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.61e-05 | 196 | 121 | 6 | 4e1f8828413896ab8a4ec92a89d6789e8e37e05a | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.65e-05 | 197 | 121 | 6 | 84ed777cdba569200a3ef1654d8a12f17fcfb7f1 | |
| ToppCell | COVID-19_Severe-T/NK_proliferative|COVID-19_Severe / Disease condition and Cell class | 1.65e-05 | 197 | 121 | 6 | 718a84e9a8248080f2d964e7c6a3ba183ece9592 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.65e-05 | 197 | 121 | 6 | 8b616cde333bdbc0c591035ad9e4949155866245 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.70e-05 | 198 | 121 | 6 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.70e-05 | 198 | 121 | 6 | 80b105a7c7d00ea3b5e586831fbb755bd84f9d1a | |
| ToppCell | Caecum-B_cell-B_cell_cycling|B_cell / Region, Cell class and subclass | 1.70e-05 | 198 | 121 | 6 | d2def132f3efe9305a5501a96ec82efb1f02c3f7 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.70e-05 | 198 | 121 | 6 | c73e906d2d12d6eba0e606958be16e63a2292cd0 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c13-MKI67-CCL5_l|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.70e-05 | 198 | 121 | 6 | 6981cd5b1585c8ae6febdf0c4fb83067127f106c | |
| ToppCell | T_cells-GZMK+GZMB+_T_cells|T_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.70e-05 | 198 | 121 | 6 | 085ba270f9defbf5ef45108c6d870e1d7c428479 | |
| ToppCell | VE-cycling|VE / Condition, Cell_class and T cell subcluster | 1.75e-05 | 199 | 121 | 6 | 47c47ebc318a0b98841ca2656837bbd068899559 | |
| ToppCell | COVID-19-Lymphoid-Proliferating_CD4_T_cells|Lymphoid / Condition, Lineage and Cell class | 1.75e-05 | 199 | 121 | 6 | 2e9ee10a069afca5dbd9f0863cf90a66db1a6ffb | |
| ToppCell | (2)_B_cell-(24)_B_cell_cycling|(2)_B_cell / shred on Cell_type and subtype | 1.75e-05 | 199 | 121 | 6 | d5a9a8a71c4de8cbcef947943f60838731bc640b | |
| ToppCell | NS-critical-d_16-33-Lymphoid-NKT-proliferating|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.75e-05 | 199 | 121 | 6 | 31b144bb209c629e12156f4d9c9cec79baffffb9 | |
| ToppCell | COVID-19-Lymphoid-Proliferating_CD4_T_cells|COVID-19 / Condition, Lineage and Cell class | 1.75e-05 | 199 | 121 | 6 | e1dfc856a85a91e8f7ab8d600a8a891d16b2aefb | |
| ToppCell | COVID-19_Mild-T/NK_proliferative|COVID-19_Mild / Disease condition and Cell class | 1.75e-05 | 199 | 121 | 6 | 9f9a88d2b099646c1e1a7ee3f8d39cb1a2498ad7 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Proliferating-cycling_ventral_progenitors|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 1.75e-05 | 199 | 121 | 6 | 446cd7d960812519fe2b8e434578ef0b668c75ce | |
| ToppCell | VE-cycling-|VE / Condition, Cell_class and T cell subcluster | 1.75e-05 | 199 | 121 | 6 | c0a67149a19b65b3069dbc5261d81f658e6e39a2 | |
| ToppCell | normal_Pleural_Fluid-T/NK_cells-Undetermined|T/NK_cells / Location, Cell class and cell subclass | 1.75e-05 | 199 | 121 | 6 | a0c20b97cb38e493b47a06e9501fc165a78c61b2 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Proliferating-Cycling_IN_Progenitors|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.75e-05 | 199 | 121 | 6 | f315ec3fb6c0799668c9195f836a77fc0db2b615 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-FOXM1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.75e-05 | 199 | 121 | 6 | 98575fcce726589e93fbb4df1aab03e57cb56076 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c10-MKI67-GZMK|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.75e-05 | 199 | 121 | 6 | 616c04b0605907fb218263f2164c36cb2fa26b87 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.80e-05 | 200 | 121 | 6 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-FOXM1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.80e-05 | 200 | 121 | 6 | 4cfe08878a6981bf7b3567f9e82192d8f060ddde | |
| ToppCell | Control_saline-Endothelial-Endothelial-FOXM1|Control_saline / Treatment groups by lineage, cell group, cell type | 1.80e-05 | 200 | 121 | 6 | 9bbc7b5561151f6ff65f40b3226271def732e5d9 | |
| ToppCell | metastatic_Lymph_Node-T/NK_cells-Undetermined|T/NK_cells / Location, Cell class and cell subclass | 1.80e-05 | 200 | 121 | 6 | 9c2095dcf70f1288d55d0ff4a97efd4fd8d0c9ee | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.80e-05 | 200 | 121 | 6 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | mild-gd_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.80e-05 | 200 | 121 | 6 | 109f673a4967ffa52270a0b4f818b3461288db44 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Proliferating|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 1.80e-05 | 200 | 121 | 6 | cea58274efbe7f9e3c3ef9fbb768ebfb917e21d9 | |
| ToppCell | Severe-T/NK_proliferative|World / Disease group and Cell class | 1.80e-05 | 200 | 121 | 6 | 128d82eb4d5760adf872212d8e8b5787a889969f | |
| ToppCell | MS-IIF-Lymphocyte-T/NK-T/NK_proliferative|IIF / Disease, condition lineage and cell class | 1.80e-05 | 200 | 121 | 6 | c7c1806a1054b2b034a26a18aac93fc3bec4dbc8 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 1.80e-05 | 200 | 121 | 6 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | tumor_Lung-T/NK_cells-Undetermined|T/NK_cells / Location, Cell class and cell subclass | 1.80e-05 | 200 | 121 | 6 | a1ef1b4824b2d56f6b2af15d698f58fc5590c392 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Stem_cells|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 1.80e-05 | 200 | 121 | 6 | 0bba93f1271dac704dddcdea8cb0f84a7ac6f42a | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Stem_cells-Neuroepithelial_cell|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 1.80e-05 | 200 | 121 | 6 | c9479452ab8c51139522383f745f02171ebbd7e2 | |
| ToppCell | LPS-antiTNF-Unknown|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.73e-05 | 129 | 121 | 5 | 739b263296c28554967362060b154f7a95e1341d | |
| ToppCell | LPS-antiTNF-Unknown-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.83e-05 | 130 | 121 | 5 | 615c233c7c2600c1c2bc5cf5b1c501fc474564ef | |
| ToppCell | LPS_only-Endothelial-Endothelial-FOXM1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.28e-05 | 134 | 121 | 5 | 4d8f7ddad02fe76a614771e115ebb8e04623ba85 | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast-Proliferative_Immature_MyoFibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 3.40e-05 | 135 | 121 | 5 | ed0f94d3839eea3b60217c4352159ed481361f13 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Dendritic-conventional_dendritic_cell-DC_c3-LAMP3|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.90e-05 | 139 | 121 | 5 | bb2b020dda32ddc60ec9952de5b01acee60b5b59 | |
| ToppCell | Control-B_naive-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 6.55e-05 | 155 | 121 | 5 | 0a78d1cab2bdba2dc8a74cdf35b5a0192370c4b5 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.76e-05 | 156 | 121 | 5 | 955547dfeb1b1ad4957b4338701055726b22619f | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 6.76e-05 | 156 | 121 | 5 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | Severe-B_naive-1|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 7.39e-05 | 159 | 121 | 5 | 2881b054bbeb479221ee3c38bbd9b0815b123579 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-stromal_related|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.84e-05 | 161 | 121 | 5 | 8aaca49b53a551395f4025ac4e535c7b0ce41a49 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-stromal_related-ICC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.84e-05 | 161 | 121 | 5 | deb10628d258fb813c293f81fb71be8e383dc82a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.81e-05 | 165 | 121 | 5 | eec2d327c94832d1390314c93ef6a2be4648478b | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.25e-05 | 49 | 67 | 5 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Computational | Neighborhood of ERBB2IP | 5.00e-05 | 65 | 67 | 5 | GCM_ERBB2IP | |
| Drug | Clorgyline | 3.30e-06 | 168 | 121 | 8 | ctd:D003010 | |
| Drug | Imipramine hydrochloride [113-52-0]; Up 200; 12.6uM; PC3; HT_HG-U133A | 7.86e-06 | 189 | 121 | 8 | 1807_UP | |
| Drug | carmustine; Up 200; 100uM; MCF7; HT_HG-U133A | 8.82e-06 | 192 | 121 | 8 | 6914_UP | |
| Drug | Tolmetin sodium salt dihydrate [64490-92-2]; Down 200; 12.6uM; HL60; HT_HG-U133A | 1.06e-05 | 197 | 121 | 8 | 3009_DN | |
| Drug | Cefoxitin sodium salt [33564-30-6]; Down 200; 8.8uM; PC3; HT_HG-U133A | 1.14e-05 | 199 | 121 | 8 | 7148_DN | |
| Disease | FANCONI ANEMIA, COMPLEMENTATION GROUP C | 1.56e-05 | 2 | 117 | 2 | C3468041 | |
| Disease | Leukemia, Myelocytic, Acute | 6.80e-05 | 173 | 117 | 6 | C0023467 | |
| Disease | macula measurement | 1.11e-04 | 189 | 117 | 6 | EFO_0008375 | |
| Disease | adenoid cystic carcinoma (is_implicated_in) | 1.55e-04 | 5 | 117 | 2 | DOID:0080202 (is_implicated_in) | |
| Disease | glutathione peroxidase 7 measurement | 2.31e-04 | 6 | 117 | 2 | EFO_0801635 | |
| Disease | Bladder Neoplasm | 2.45e-04 | 140 | 117 | 5 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 2.53e-04 | 141 | 117 | 5 | C0005684 | |
| Disease | Dickkopf-related protein 4 measurement | 4.30e-04 | 8 | 117 | 2 | EFO_0008110 | |
| Disease | allergic rhinitis (biomarker_via_orthology) | 6.87e-04 | 10 | 117 | 2 | DOID:4481 (biomarker_via_orthology) | |
| Disease | Oligospermia | 1.00e-03 | 12 | 117 | 2 | C0028960 | |
| Disease | dickkopf‐related protein 1 measurement | 1.00e-03 | 12 | 117 | 2 | EFO_0010620 | |
| Disease | factor VII measurement | 1.37e-03 | 55 | 117 | 3 | EFO_0004619 | |
| Disease | Fanconi anemia | 1.38e-03 | 14 | 117 | 2 | cv:C0015625 | |
| Disease | Majewski Syndrome | 1.38e-03 | 14 | 117 | 2 | C0024507 | |
| Disease | colorectal cancer (is_implicated_in) | 1.40e-03 | 121 | 117 | 4 | DOID:9256 (is_implicated_in) | |
| Disease | matrix metalloproteinase 1 measurement | 1.58e-03 | 15 | 117 | 2 | EFO_0010588 | |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 1.58e-03 | 15 | 117 | 2 | C0496930 | |
| Disease | Benign neoplasm of bladder | 1.58e-03 | 15 | 117 | 2 | C0154017 | |
| Disease | Carcinoma in situ of bladder | 1.58e-03 | 15 | 117 | 2 | C0154091 | |
| Disease | Dermatitis | 1.80e-03 | 16 | 117 | 2 | C0011603 | |
| Disease | Amyotrophic lateral sclerosis | 2.04e-03 | 17 | 117 | 2 | cv:C0002736 | |
| Disease | matrix metalloproteinase 12 measurement | 2.29e-03 | 18 | 117 | 2 | EFO_0010590 | |
| Disease | Bone marrow hypocellularity | 2.29e-03 | 18 | 117 | 2 | C1855710 | |
| Disease | Carcinoma of bladder | 2.29e-03 | 18 | 117 | 2 | C0699885 | |
| Disease | MYELODYSPLASTIC SYNDROME | 2.42e-03 | 67 | 117 | 3 | C3463824 | |
| Disease | Congenital Myasthenic Syndromes, Presynaptic | 2.55e-03 | 19 | 117 | 2 | C0751884 | |
| Disease | type 1 diabetes mellitus (biomarker_via_orthology) | 2.55e-03 | 19 | 117 | 2 | DOID:9744 (biomarker_via_orthology) | |
| Disease | Seckel syndrome | 3.42e-03 | 22 | 117 | 2 | C0265202 | |
| Disease | calcium measurement | 3.61e-03 | 628 | 117 | 8 | EFO_0004838 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KSICANSPIKAQQDQ | 296 | A8K979 | |
| NNCNPLTKESIRQKE | 86 | Q8WV16 | |
| RQKLQCVASKLQVLP | 3516 | Q99996 | |
| LNPCRTGKIKSLQNN | 631 | Q99708 | |
| QIFNNRNCLSLKDKP | 236 | P49662 | |
| SQQQPRCKQKVIFGS | 956 | P41180 | |
| LKCNQNCLKTAGNPR | 191 | Q9HAK2 | |
| PKVKNPCLNVQSQRS | 1226 | Q9UKA4 | |
| KQQQLLAACKSLPSS | 571 | Q99490 | |
| LKNQTQVKLNIVSCP | 641 | Q99767 | |
| KKQRPLTASLQCNST | 81 | Q9UFW8 | |
| QPICFDRQSTLKKTN | 86 | Q8TAP6 | |
| SQRPVLKVCNHENQK | 1096 | Q9NSV4 | |
| KALCPTRENFNSQQK | 1601 | Q9UPY3 | |
| RPVNKCSDQIKLKNT | 1496 | Q12830 | |
| NNRNCQSLKDKPKVI | 201 | Q6UXS9 | |
| KKQQQQCRPSISISS | 176 | Q76L83 | |
| QQKRLLPSCSFQQNL | 1896 | Q9C0F0 | |
| TPQTLSNLCLKINVK | 556 | Q9UKV8 | |
| LTNASQCQPVQPKKE | 66 | Q8WWL7 | |
| PVQKKSKNRTNCDIN | 361 | Q8IWA6 | |
| NKCDLREQIQVPSNL | 151 | Q14088 | |
| VSSKNRIPQEKCILQ | 221 | Q9H0G5 | |
| DQILTNLSKRKCPSQ | 426 | Q15113 | |
| AALQAQKNCKETLPR | 321 | Q9ULG1 | |
| NRDVLLCQKLEQKNP | 391 | Q2M385 | |
| ALCRTPANKLKNKEN | 411 | Q14680 | |
| LQCSNRKELVNPNFK | 241 | Q08999 | |
| CRNKPNQFIRIKNNI | 1296 | Q7Z5J8 | |
| QLNALLEQESRCQPK | 16 | P51959 | |
| LAQLNKCTSPQQKLV | 271 | Q96NW4 | |
| QRKQRDCVNQCKSKP | 6 | Q8WWY6 | |
| IKQTQCPADPLQLNK | 426 | Q96JP0 | |
| PRASQNCLSKQQLLS | 21 | Q53RD9 | |
| TLKLNPLQENCNAVR | 156 | O60320 | |
| LRCENIQPNPTEKQK | 406 | Q8TDR0 | |
| RKQQNEVSSCIPKIL | 191 | Q9NVX0 | |
| NKKSSCLQISLQPTR | 81 | P46934 | |
| LPVQFCQLQELKNLK | 241 | Q96L50 | |
| KPKAAEVCQQSNQKR | 1051 | Q5T848 | |
| NAANLIKKLCRDNPS | 586 | Q13976 | |
| CEKKTQLFLTNQRPE | 441 | Q8WW38 | |
| LCNLPQGSLQNKTKL | 401 | O15550 | |
| VVRLCQNPKLQLKNS | 56 | Q13191 | |
| RRIPKKSSQCNGQVL | 686 | Q5SYE7 | |
| PATKCPNSKLNLNQL | 271 | Q86YR7 | |
| SGQLPNKKNCRTNIS | 666 | Q9UHC1 | |
| RNFPELLSLNLCNNK | 156 | Q9H1B4 | |
| CQLSQRLQESLKKVN | 361 | Q6P996 | |
| NASRSPEKCAQQRQK | 781 | Q99550 | |
| PEKCAQQRQKRLNSA | 786 | Q99550 | |
| LCNSEQQRGKENLPK | 521 | Q13614 | |
| EKVNSQPRLVQQAKC | 451 | Q8NA19 | |
| NKLPIKILCLSNNQI | 256 | Q96M69 | |
| GRPTKKLQQQCQFIT | 1231 | Q9BZ72 | |
| SKEPLKNLNSCLQQL | 1421 | Q08378 | |
| QAKNCPISAKLERLQ | 4821 | Q9UPN3 | |
| LKCQNRVIKLSTNPF | 521 | Q8NB91 | |
| KLHRVNQVKCQLPES | 576 | Q9UII4 | |
| QLSNNPVKGRTCKER | 651 | P05107 | |
| VQKLASALLNQKCPL | 4111 | Q8NCM8 | |
| QQNSCNRVPKILIDK | 681 | Q13535 | |
| NNRNCLSLKDKPKVI | 296 | P51878 | |
| SQRNDIQEKCVKLLP | 391 | Q96M89 | |
| NIPCAVTKRNNLRKA | 496 | P13671 | |
| KSNLPLNKTQQFNIC | 1046 | Q9P2H0 | |
| CLRNKDLPQQLKNPA | 246 | Q6P4F1 | |
| CLINKEPQNSGQSKL | 96 | Q00597 | |
| RLKGCENKQPQKTSQ | 236 | Q3MJ40 | |
| ASINRVNSCLKKNLP | 66 | Q9UKJ5 | |
| QQCKINVRDSENKSP | 81 | Q92527 | |
| ENKSPLIKAVQCQNE | 91 | Q92527 | |
| SNRQPAKLNLLTCQV | 361 | Q9ULH1 | |
| RQNCKGDSQPNKSIR | 1441 | Q9NSI6 | |
| VVRLCQNPKLALKNS | 66 | P22681 | |
| RLKGCENKQPQKTSQ | 236 | A2RUR9 | |
| QTLKPQNRKVDCNKG | 21 | P59796 | |
| STPEQLSKRLQNFCK | 406 | Q4AE62 | |
| RCNLIPEKQDINSTN | 671 | P10243 | |
| INLKIKCNRLNSIDP | 2176 | A6NMZ7 | |
| LRILTCEPSQNKQKG | 341 | Q96LW4 | |
| QEKCQALERKNSAIP | 331 | Q96CV9 | |
| CKQRLPQLNSKDNKF | 296 | Q96FC7 | |
| CQRLQKQINKLSDQS | 456 | Q86VP1 | |
| NKDICLPESNNQVKT | 376 | Q8IYR2 | |
| QCSQKKAQKITELRP | 406 | Q9H4L7 | |
| CVPNLQRLNLDSNKL | 276 | Q86VH5 | |
| CPQLAEKKQQFRSLK | 261 | Q3BBV2 | |
| CPQLAEKKQQFRSLK | 296 | Q86T75 | |
| TVANLNRIKLNSKQC | 56 | Q6P1X5 | |
| AKIKQNRVLVCAPSN | 1996 | Q7Z333 | |
| AKNPNLRKNVLCGNI | 201 | P23193 | |
| CNQKVLRFDPTQLTK | 441 | Q6NSI8 | |
| IRQKSDNIQPENLSC | 106 | Q6ZWJ1 | |
| EKTLVQNNCLTRPNI | 156 | Q92922 | |
| RQQIKDFTCNPLNSI | 436 | Q86YF9 | |
| LIQCLTKELNEKQPS | 476 | Q8NHS4 | |
| KNNCQNQPPSKSTIR | 41 | Q8IYA6 | |
| SCVLQKSKAISQRPN | 366 | Q8IYA6 | |
| SQPQISRICKNKEKL | 41 | Q6B0B8 | |
| TQKGRQTERKPNECN | 226 | Q9HCZ1 | |
| ECSERRQKNQNKLPK | 406 | P21580 | |
| LQVCKALLQKLASPN | 626 | Q96MK2 | |
| CQKGLQLAKENPQRT | 476 | Q96PX9 | |
| TNEAEKLQKPSNCLQ | 906 | Q9P2F5 | |
| QTPSCKIQKLSLQNC | 81 | P13489 | |
| CLQNKPKISELARNI | 51 | Q4J6C6 | |
| PLCSLNNTRVKNSKR | 1541 | Q86WI1 | |
| SPQDKRTLLVNCQNK | 186 | Q8TC07 | |
| KIQQCVVANKLPRNR | 11 | Q6IQ21 | |
| PLTCNKNLTHRKDQQ | 121 | Q86XU0 | |
| ALNPNEIQRALVQCK | 1371 | A7E2V4 | |
| RNSLRQTNKTKQSCP | 256 | P33981 | |
| LKSRNLLKKNNSCSP | 91 | Q9H0W7 | |
| NSKRSLKQPLEQNQT | 396 | Q9UQR1 | |
| QCLSKTQQKSRELNN | 411 | Q9HBM0 | |
| HSPNQRLLKSVQQCN | 91 | Q8N883 | |
| LCSPQVNQKSKALLV | 1116 | Q9BZH6 | |
| VKSKLCNLRNLPPQA | 141 | Q9H9Y6 | |
| NTPNCALQIVARLKN | 51 | P48061 | |
| ARLKNNNRQVCIDPK | 61 | P48061 | |
| GEKCALQNSPRSQKQ | 201 | Q5TAX3 | |
| SPQLDTQQEIKLCQK | 266 | Q9HAD4 | |
| QPVKKQQENATSCSL | 381 | Q9HAD4 | |
| ISQPCQKSSQLCQKV | 1306 | Q6PFW1 | |
| RQKPCIVKNVENLLN | 421 | Q5JVG8 | |
| QGKSLTLPQTCNREK | 221 | Q2M3W8 | |
| CLKESPNKQQERAQS | 1226 | B2RTY4 |